
Director, Raw Materials Center of Excellence Strategy Lead
Merck
Summary
The Strategy Lead Director will set the strategy for the Raw Materials Center of Excellence, establishing harmonized, science- and risk-based approaches to control and release testing of raw materials, excipients, and package components across the full clinical portfolio of small molecules, biologics, and vaccines. As the technical authority for raw materials, the Strategy Lead Director will ensure that Center of Excellence standards, processes, and testing strategies support cGMP compliance, operational excellence, and continuous inspection readiness.
Job description
Role Summary
The Strategy Lead Director will set the strategy for the Raw Materials Center of Excellence, establishing harmonized, science- and risk-based approaches to control and release testing of raw materials, excipients, and package components across the full clinical portfolio of small molecules, biologics, and vaccines. As the technical authority for raw materials, the Strategy Lead Director will ensure that Center of Excellence standards, processes, and testing strategies support cGMP compliance, operational excellence, and continuous inspection readiness.
Primary Responsibilities
- Define and drive the strategy, governance, and multi-year roadmap for the Raw Materials Center of Excellence, partnering cross-functionally with Analytical Leadership, Quality, Procurement, Materials Management, and Pharmaceutical Sciences.
- Establish science- and risk-based raw material control strategies, including specification setting, supplier qualification input, and reduced testing programs.
- Provide technical oversight of contract laboratories and lead scientific support for raw material investigations, deviations, and CAPAs.
- Review and approve GMP data, release specifications, analytical reports, Certificates of Analysis, and SOPs; author and own Center of Excellence standards and governance documents.
- Serve as the raw material SME during internal and external compliance audits and regulatory inspections; monitor regulatory, compendial, and industry trends and lead gap assessments and implementation plans.
- Champion operational excellence in raw material testing through digital tools and innovative technologies, ensuring data integrity and right-first-time execution.
- Mentor scientists, building technical depth and raw materials expertise across the Center of Excellence.
Education Minimum Requirements
- PhD Degree in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences or related fields with at least 7 years of pharmaceutical industry experience.
- Master's Degree in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences or related fields with at least 10 years of pharmaceutical industry experience.
- Bachelor's Degree in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences or related fields with at least 12 years of pharmaceutical industry experience.
Required Experience and Skills
- Extensive expertise in the analytical testing of raw materials, excipients, and/or package components, preferably within a cGMP environment, with comprehensive knowledge of GMPs, ICH guidelines, compendial requirements, and applicable FDA guidance.
- Demonstrated ability to develop and execute technical strategy and to exercise influence without direct authority within a matrixed organization.
- Excellent scientific communication, creativity, and interpersonal skills, with proven experience mentoring scientists and collaborating cross-functionally in a team-based environment.
Preferred Experience and Skills
- Experience establishing or driving a center of excellence or global harmonization initiative.
- Implementing risk-based raw material control strategies (e.g., reduced testing, supplier qualification programs).
- Overseeing contract laboratories.
- Familiarity with compendial monograph changes, digital solutions for lab operations, and package or medical device components.
Requirements
- PhD Degree in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences or related fields with at least 7 years of pharmaceutical industry experience
- Master's Degree in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences or related fields with at least 10 years of pharmaceutical industry experience
- Bachelor's Degree in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences or related fields with at least 12 years of pharmaceutical industry experience
- Extensive expertise in analytical testing of raw materials, excipients, and/or package components
- Comprehensive knowledge of GMPs, ICH guidelines, compendial requirements, and applicable FDA guidance
- Demonstrated ability to develop and execute technical strategy
- Ability to exercise influence without direct authority within a matrixed organization
- Excellent scientific communication, creativity, and interpersonal skills
- Proven experience mentoring scientists
- Cross-functional collaboration in a team-based environment
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate & Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.